Source: Υπουργείο Υγείας (CY) Revision Year: 2014 Publisher: HEXAL AG, Industriestraße 25, D-83607 Holzkirchen, Telephone: +49 (0) 80 24 / 908-0, Telefax: +49 (0) 80 24 / 908-1290, e-mail: service@hexal.de <u>Distributor in Cyprus:</u> P.T.Hadjigeorgiou Co Ltd, ...
Diclac 50 HEXAL Enteric-Coated Tablets.
Pharmaceutical Form |
---|
Diclac 50 HEXAL: Enteric-coated tablets. |
Pharmacologically active ingredients:
One Diclac 50 HEXAL enteric-coated tablet contains: 50 mg diclofenac sodium.
Additional inactive ingredients: see point 6.1.
Active Ingredient | Description | |
---|---|---|
Diclofenac |
Diclofenac is a non-steroidal anti-inflammatory drug. The mechanism of action of diclofenac in AK may be related to the inhibition of the cycloxygenase pathway leading to reduced prostaglandin E2 (PGE2) synthesis. In addition, immunohistochemistry (IHC) from skin biopsies ac revealed that the clinical effects of diclofenac in AK are primarily due to anti-inflammatory, anti-angiogenic and possibly anti-proliferative effects and apoptosis-inducing mechanisms. |
List of Excipients |
---|
Diclac 50 HEXAL enteric-coated tabletLactose 1H2O Film-coating: Eudragit L 30 D Advice to diabetics: The tablet contains less than 0.01 carbohydrate exchange units. |
Original package containing 10, 20, 30, 50 and 60 enteric-coated tablets.
HEXAL AG, Industriestraße 25, D-83607 Holzkirchen, Telephone: +49 (0) 80 24 / 908-0, Telefax: +49 (0) 80 24 / 908-1290, e-mail: service@hexal.de
Distributor in Cyprus:
P.T.Hadjigeorgiou Co Ltd, P.O.Box 53158-3301, Limassol, Cyprus, Tel: 25372425, Fax: 25376400, e-mail: hapanicos@cytanet.com.cy
19654
30/04/04
Drug | Countries | |
---|---|---|
DICLAC | Brazil, Cyprus, Germany, Estonia, Croatia, Ireland, Lithuania, Malta, Poland, Romania |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.